Why Picking the Right Panel Makes All the Difference
In the realm of proteomics, selecting an appropriate analytical panel is paramount to the success of your research. With the advent of high-throughput technologies, Olink has emerged as a leader in providing multiplex immunoassay panels that enable the simultaneous quantification of numerous proteins from minimal sample volumes.
However, with a diverse array of panels available—ranging from the extensive Olink Explore HT to the targeted Olink Target series—researchers often face the challenge of choosing the panel that best aligns with their specific study objectives. Making an informed decision is crucial, as the wrong choice can lead to suboptimal data, increased costs, and potential delays in research timelines.
This guide aims to demystify selecting the right Olink panel by providing a structured approach to match your research goals with the most suitable panel. By understanding the unique features and applications of each panel, you can ensure that your study is equipped with the tools necessary to achieve meaningful and reproducible results.
A heatmap or bar graph showing number of proteins vs sample volume vs throughput across panels (e.g. comparison of Olink Explore vs SomaScan from Wang et al. 2025)
One-Minute Overview: All Olink Panel Families
Olink offers a variety of proteomics panels designed to meet the diverse needs of researchers at different stages of their studies. Whether you're conducting a broad discovery study, validating specific biomarkers, or monitoring immune responses, there is a panel for you. Here's a quick look at the available Olink panel families:
Explore HT: This panel is designed for high-throughput, discovery-scale research, covering over 5,400 proteins across various sample types like plasma, serum, and more. It's ideal for large-scale studies and population research, enabling high multiplexing and fast analysis with NGS technology.
Explore 3072 / Modular 384-plex Panels: These modular panels allow you to select up to 3072 proteins by combining multiple 384-plex subpanels. This flexibility is perfect for studying specific disease areas or biological processes without a complete proteome-wide analysis.
Target 96: Focused on hypothesis-driven research, the Target 96 panel provides 92 proteins per panel.It is designed to validate biomarkers and explore disease pathways, making it ideal for clinical and translational studies. The qPCR-based readout allows for precise quantification.
Target 48 (Cytokine / Immune Surveillance): This panel is tailored explicitly for monitoring immune responses and cytokine profiling, with around 45 proteins targeting immune and inflammatory markers. It's often used in clinical trials, preclinical studies, and immune-oncology research.
Target 48 Mouse Cytokine: A specialized version of the Target 48 panel for mouse models, this panel offers 43 proteins crucial for studying immune responses and cytokine levels in preclinical studies.
Flex: The Flex panel is highly customizable, allowing you to select 5–30 biomarkers from a library of around 200 pre-validated assays. It's perfect for researchers with a clear set of biomarkers in mind who need panel design flexibility.
Focus: For those looking for a more targeted approach, the Focus panel offers customization of up to 21 proteins from a library of 5,000+ assays. It's ideal for validating findings or conducting more precise studies.
Reveal: The Reveal panel is an accessible solution for labs new to high-throughput proteomics. It offers streamlined, lower-barrier NGS-based proteomics, making it a great starting point for those looking to perform discovery proteomics without the complexity or high cost of full-scale panels like Explore HT.
These panels support various research needs, from early-stage discovery to focused validation and clinical translation. Selecting the right panel for your project depends on your research goals, sample type, and budget.
This overview will help guide you as you explore your options, but keep reading for a more in-depth comparison to find the panel that best fits your needs.
Panel Comparison Table: Key Specs Side by Side
To help you make a well-informed decision, we've created a comparison table of the key specifications for each Olink panel. This table highlights differences in sample requirements, number of biomarkers, quantification methods, throughput, and ideal use cases for each panel. Use this table to identify which panel aligns with your research objectives quickly.
Panel Name | Sample Volume & Type | Number of Proteins / Biomarkers | Read-out Method | Quantification | Throughput / Kit Size | Best Use Cases | Limitations / Trade-offs |
Explore HT | ~2 µL; plasma, serum, and other standard biological fluids | >5,400 proteins | NGS | Relative (NPX) | Very high throughput (hundreds to thousands of samples per week) | Large-scale discovery; population studies; biomarker identification | Higher cost per sample; large data sets require robust bioinformatics; not ideal for highly specific validation |
Explore 3072 / 384-plex Modular | ~2 µL; plasma/serum and other fluids | ~3,000 proteins (if combining modules) | NGS | Relative (NPX) | High throughput; scalable depending on module selection | When broad coverage is needed but not at full proteome scale; customized disease area profiling | Adding multiple modules increases complexity and QC demands; requires precise sample handling |
Target 96 | ~1 µL; plasma, serum, and validated fluids | 92 proteins per panel; multiple disease panels | qPCR (Signature Q100) | Relative (NPX) | Moderate throughput; ~88 samples per kit | Disease-focused research; hypothesis-driven validation; clinical and translational studies | Limited breadth compared to Explore panels; may require additional panels for broader biomarker coverage |
Target 48 (Human Cytokine / Immune Surveillance) | ~1 µL; plasma/serum, other validated fluids | ~44-45 proteins (human); ~43 proteins (mouse) | qPCR (Signature Q100) | Absolute (pg/mL) or relative (NPX) | Moderate throughput; ~40-80 samples per kit | Immune response profiling; cytokine research; preclinical and clinical trials | Narrower protein coverage; not ideal for large discovery efforts or extensive proteome-wide studies |
Flex | ~1 µL; standard sample types | Customizable: 5-30 proteins from a library of ~200 assays | qPCR (Signature Q100) | Absolute or relative (NPX) | Lower throughput; flexible design | When specific biomarkers are known and need to be validated; tailored for pathways and signatures | Custom design can lead to longer setup times; each assay must be validated |
Focus | ~1 µL; standard biological fluids | Customizable: up to ~21 proteins from a library of 5,000+ assays | qPCR (Signature Q100) | Absolute or relative (NPX) | Low throughput; ~40 samples per kit | Validation of biomarkers; high precision required for clinical or preclinical research | Limited to smaller biomarker sets; customization may take longer |
Reveal | ~1-2 µL; standard biological fluids | Moderate (~1,000+ proteins depending on configuration) | NGS | Relative (NPX) | Moderate throughput | Accessible discovery for labs new to high-plex proteomics; lower barrier to entry for large-scale studies | Less coverage than Explore HT; lower sensitivity for very low abundance proteins; potential for incomplete biomarker discovery |
This table offers a comprehensive, side-by-side look at Olink's core panels. It helps you quickly assess which option suits your study based on throughput, sample volume, number of biomarkers, and research goals. Keep in mind that the "best fit" often depends on balancing discovery breadth with your specific research question.
For more detailed guidance on selecting the right panel for your study, read on. We'll walk you through the decision-making framework to help you choose the most appropriate Olink panel.
Start with Your Question
Choosing the right Olink panel begins with a clear understanding of your research objectives. Each panel is tailored to specific study goals, sample types, and throughput needs. Here's how to align your research focus with the most suitable Olink panel:
1. Discovery vs. Validation
Discovery Studies: If your goal is to explore a broad range of proteins to identify novel biomarkers or gain comprehensive insights into disease mechanisms, the Olink Explore HT or Explore 3072 panels are ideal. These panels offer extensive coverage and are designed for high-throughput analysis.
Validation Studies: For confirming specific biomarkers or pathways previously identified, the Olink Target 96 panel provides a focused approach with 92 proteins per panel, facilitating detailed validation in a targeted manner.
2. Immune & Cytokine Profiling
Human Immune Profiling: The Olink Target 48 Cytokine panel is tailored for studying human immune responses, offering simultaneous analysis of 45 cytokines with high specificity.
Mouse Immune Profiling: For preclinical studies involving mouse models, the Olink Target 48 Mouse Cytokine panel enables in-depth analysis of 43 cytokines, supporting translational research from bench to bedside.
3. Sample Types & Throughput
Sample Volume: Most Olink panels require minimal sample volumes, typically around 1 µL, making them suitable for precious or limited samples.
Throughput Needs: Consider the number of samples you plan to analyze. High-throughput panels like Explore HT accommodate large sample sizes efficiently, whereas panels like Target 96 are better suited for moderate sample numbers.
4. Quantification Methods
Relative Quantification: Panels such as Explore HT and Target 96 provide relative quantification, ideal for comparing protein levels across different conditions.
Absolute Quantification: For precise measurement of protein concentrations, the Target 48 Cytokine panel offers absolute quantification, reporting results in standard units like pg/mL.
5. Research Focus Areas
Inflammation & Immune Response: Panels like Target 48 Cytokine and Target 48 Mouse Cytokine are specifically designed for studying inflammatory pathways and immune responses.
Oncology & Neurology: For cancer or neurological research, consider the relevant panels under the Explore 3072 or Target 96 series, which include biomarkers pertinent to these fields.
By aligning your research objectives with the appropriate Olink panel, you can ensure that your study design is optimized for the questions you aim to answer. For a more detailed comparison of panel specifications, refer to the earlier section on panel specifications.
Next Steps: Once you've identified the panel that best fits your research needs, consider the following:
- Sample Preparation: Ensure that your samples are collected and stored according to the guidelines provided for the chosen panel.
- Data Analysis: Familiarize yourself with the data analysis tools and software compatible with your selected panel to facilitate efficient data interpretation.
- Consultation: If you need further assistance in selecting the right panel or have specific questions about your study design, don't hesitate to reach out to Creative Proteomics's support team or a certified service provider.
- By carefully considering these factors, you can make an informed decision that enhances the quality and impact of your research.
Integrating Olink Panels with Other Omics Technologies
To gain a comprehensive understanding of biological systems, integrating proteomics data from Olink panels with other omics layers—such as genomics, transcriptomics, metabolomics, and microbiomics—can provide deeper insights into disease mechanisms and therapeutic responses.
Multi-Omics Integration with Olink Proteomics
Olink's Proximity Extension Assay (PEA) technology offers high specificity and sensitivity, enabling accurate protein quantification. When combined with other omics data, researchers can achieve a holistic view of biological processes.
Genomics: Integrating proteomics with genomic data can help identify gene-protein associations, elucidate gene expression regulation, and uncover genetic variants influencing protein levels.
Transcriptomics: Combining proteomics with transcriptomics allows for the correlation of mRNA expression levels with protein abundance, aiding in understanding post-transcriptional regulation and protein synthesis.
Metabolomics: Linking proteomics with metabolomics can reveal how metabolic changes influence protein function and vice versa, providing insights into metabolic pathways and disease states.
Microbiomics: Integrating proteomics with microbiome data can uncover host-microbe interactions and their impact on health and disease.
By leveraging Olink's high-throughput proteomics capabilities and integrating them with other omics data, researchers can achieve a systems-level understanding of complex biological questions.
Cytokine-Focused Choices: Target 48 vs. Target 48 Mouse
If your research centers around cytokines, immune response, or inflammation:
Use Target 48 Cytokine / Immune Surveillance for human studies; it gives you ~45 critical proteins. Results often include absolute concentration (e.g. pg/mL) and/or NPX.
For mouse models, Target 48 Mouse Cytokine lets you do longitudinal sampling and immune monitoring in preclinical settings.
Combine with panels for tissue or plasma proteomics if you expect cross-tissue or systemic effects beyond immune markers.
Comparative Overview
Feature | Target 48 Cytokine (Human) | Target 48 Mouse Cytokine |
Species | Human | Mouse |
Biomarkers | 45 | 43 |
Sample Volume | 1 µL | 1 µL |
Quantification | Absolute & Relative | Absolute & Relative |
Ideal For | Clinical Studies | Preclinical Research |
Longitudinal Studies | Limited | Yes |
Compatibility | Olink Signature Q100 | Olink Signature Q100 |
Choosing between these panels depends on your study's species focus and research objectives. For human clinical studies, the Target 48 Cytokine panel is appropriate, whereas for mouse model research, the Target 48 Mouse Cytokine panel is more suitable.
Data Reality Check: NPX vs Absolute Units & Quantification Considerations
NPX (Normalized Protein Expression) is Olink's relative quantification unit. It's typically log2-transformed, dependent on proper normalization (intra- and inter-assay). It works well for comparing the same protein across samples in the same run/project.
Absolute quantification (e.g. pg/mL) is available in some Target 48 / Immune / Cytokine panels; this is especially useful for clinical translation, comparing across studies or labs, or meeting regulatory / longitudinal comparability needs.
Make sure to plan downstream analysis early: consider limits of detection (LOD), coefficient of variation (CV) specifications, sample quality, batch effects. A panel may cover many proteins but if many are near the detection limit for your sample type, they may not yield reliable data.
Practical Scenarios: Which Panel Fits Your Project?
Scenario | Recommended Panel(s) | Why It's a Good Fit |
Large cohort study to discover new biomarkers (e.g. population / biobank) | Explore HT or Explore Modular (3072/384) | Maximum coverage; high throughput; efficient sample input; powerful discovery potential |
Disease-focused pathway / mechanism work (e.g. neurodegeneration, cardio, metabolic) | Target 96 or Focus | Balanced breadth and cost; enough coverage to see pathway effects without overwhelming data load |
Immune response monitoring (clinical trials, vaccine, toxicity) | Target 48 Cytokine / Immune Surveillance; possibly Target 48 Mouse for preclinical | Focused on cytokine/immune proteins; better quantitation; suited for repeated sampling |
Small number of candidate proteins already known, requiring precise quantitation | Focus or Flex (custom) | You can select only what you need; better quantitation; lower background; faster validation |
Limited sample volume, or non-plasma/serum sample types (CSF, tissue, lysates) | Pick panels validated on sample matrix; often Explore HT or Target 96 (if validated) but check validation data | Sample input & matrix compatibility critical to obtaining usable data; may need to pilot test |
Putting It Together: How to Decide
To make your decision more systematic, you might use a checklist like this:
Question | If "Yes" → favor panel with … |
Do I need precise concentrations (absolute data)? | A panel offering absolute quantification like Target 48 Cytokine |
Are my target proteins low in abundance or in difficult matrices? | A panel with high sensitivity and strong validation data (e.g. Explore HT or well-validated Target panel) |
How many samples do I process? | If many, high-throughput panels; if fewer, focused panels suffice |
Is cross-site or cross-lab comparison important? | Look for panels with strong reproducibility, absolute quantification, and rigorous specificity testing |
To help you understand background and related issues, these articles can deepen your knowledge:
Introduction to Olink Proteomics: What You Need to Know (for basic concepts, technology overview)
Exploring the Olink 96 and 48-Plex Panels: Key Differences (for throughput vs panel size trade-offs)
Understanding Olink's Data Analysis Process: From Raw Data to Insights (for NPX, QC, normalization etc.)
Olink's Plasma Proteomics: Unlocking Insights for Disease Research (for sample-matrix and disease study examples)
References
- Sattlecker, M., et al. (2023). "Blood-based proteomic profiling in preclinical and prodromal Alzheimer's disease." Nature Medicine, 29, 305–315.
- Lind, L., et al. (2022). "Circulating proteins and risk of heart failure: a proteomic approach in two community-based cohorts." European Heart Journal
- Multiplex analysis of inflammatory proteins: A comparative study across multiple platforms